1. Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC 
Karin J.C. Sanders, MD, Lizza E. Hendriks, MD, Esther G.C. Troost, MD, PhD, Gerben P. Bootsma, MD, PhD, Ruud M.A. Houben, MSc, Annemie M.W.J. Schols, PhD, Anne-Marie C. Dingemans, MD, PhD 
Journal of Thoracic Oncology 
Volume 11, Issue 6, Pages (June 2016)
DOI: /j.jtho
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1 Flowchart detailing the study population.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Survival analyses. (A) Kaplan Meier overall survival (OS) curve; (B) Kaplan Meier progression-free survival (PFS) curve for patients experiencing early weight loss of more than 5% (solid line) compared with for patients with early weight loss of 5% or less (dotted line).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

4. Supplemental Data 1
The course of mean (± standard error of the mean) weight loss during therapy of patients experiencing >5% early weight loss (solid line) compared to patients with ≤5% early weight loss (dotted line).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions